Experiencia argentina en el abordaje de la tuberculosis extensamente resistente
Abbate, Eduardo; Vescovo, Marisa; Cufré, Mónica; Natiello, Marcela; García, Ana; González Montaner, Pablo.
Salud(i)cienc., (Impresa)
; 17(8): 778-782, sept. 2010.
Artículo en Español | BINACIS | ID: bin-125570
Documentos relacionados
More Tailored Approaches to Tuberculosis Treatment and Prevention.
Transmission of multidrug-resistant tuberculosis within family households by DTM-PCR and MIRU-VNTR genotyping.
Time to commencement of effective treatment in patients with drug-resistant tuberculosis diagnosed in the Torres Strait-Papua New Guinea cross-border region.
Improving tuberculosis surveillance by detecting international transmission using publicly available whole genome sequencing data.
Genomic Profiling of Mycobacterium tuberculosis Strains, Myanmar.
Heteroresistance to rifampicin & isoniazid in clinical samples of patients with presumptive drug-resistant tuberculosis in Central India.
Determinants of catastrophic costs among households affected by multi-drug resistant tuberculosis in Ho Chi Minh City, Viet Nam: a prospective cohort study.
Resistance Profiles to Second-Line Anti-Tuberculosis Drugs and Their Treatment Outcomes: A Three-Year Retrospective Analysis from South India.
Emergence and evolution of drug-resistant Mycobacterium tuberculosis in eastern China: A six-year prospective study.
How has the municipal availability of the GeneXpert®MTB/RIF system affected the detection of drug-resistant tuberculosis in Brazil?